Role of natriuretic peptides and cardiac troponins in staging hypertensive heart disease: the REMODEL study
NT-proBNP and hsTnT are complementary biomarkers that not only predict cardiovascular outcomes and but also reflect the severity of cardiac remodelling in HHD. Their combined use enables effective staging of disease severity and may support stage-specific management strategies in patients with hypertension.
Authors
- Soon Kieng Phua (ORCID: https://orcid.org/0000-0002-7486-689X)
- Thu-Thao Le
- Javier Muñiz Sáenz Diez
- C Y Chin
- Ashley Sharp
- Tar-Choon Aw
- Javed Butler
- A Mark Richards
- Michael Böhm
Institutions
- University of Dundee (GB)
- Changi General Hospital (SG)
- University of Mississippi (US)
- Universitätsklinikum des Saarlandes (DE)
- Baylor Medical Center at Garland (US)
- Duke-NUS Medical School (SG)
- National Heart Centre Singapore (SG)
- Christ University (IN)
- University of Otago (NZ)
- Universidad de Navarra (ES)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1093/ejhf/xuaf001
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 30.07